Marshall Fordyce - Dec 29, 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
President and CEO, Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Dec 29, 2023
Transactions value $
$38,854
Form type
4
Date filed
1/3/2024, 04:15 PM
Previous filing
Aug 23, 2023
Next filing
Jan 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise $1.2K +516 +0.21% $2.32 244K Dec 29, 2023 Direct
transaction VERA Class A Common Stock Options Exercise $37.7K +13K +5.33% $2.90 257K Dec 29, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (Right to Buy) Options Exercise $0 -516 -100% $0.00* 0 Dec 29, 2023 Class A Common Stock 516 $2.32 Direct F1
transaction VERA Stock Option (Right to Buy) Options Exercise $0 -13K -1.47% $0.00 874K Dec 29, 2023 Class A Common Stock 13K $2.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares subject to the option vested on January 10, 2021, and 1/36 of the shares vest monthly thereafter.
F2 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.